SciVision Biotech Inc. (1786.TW)
Taiwan · TWD · Healthcare · Medical Instruments & Supplies
NT$39.00 (-1.76%) as of
Key statistics
- Market cap
- 2.83B
- P/E (TTM)
- 16.81
- Forward P/E
- 5.68
- EPS (TTM)
- 2.32
- Dividend yield
- 4.81%
- 52-week range
- 39.00 – 92.00
- Beta
- 0.48
- Revenue (TTM)
- 889.15M
- Profit margin
- 20.03%
- Volume
- 221.11k
About SciVision Biotech Inc.
SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Kaohsiung, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.